Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a multicenter clinical experience
Alessandro Russo, Sara Palma Gullì, A D’Avino, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 1, pp. 107190-107190
Closed Access | Times Cited: 8

Showing 8 citing articles:

Antibiotic Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence
Francesca Serapide, Maurizio Guastalegname, Sara Palma Gullì, et al.
Antibiotics (2024) Vol. 13, Iss. 6, pp. 506-506
Open Access | Times Cited: 12
Antibiotic Treatment of Carbapenem-Resistant <em>Acinetobacter baumannii </em>Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence
Francesca Serapide, Maurizio Guastalegname, Sara Palma Gullì, et al.
(2024)
Open Access | Times Cited: 6
Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS Study
Klaus‐Friedrich Bodmann, Stefan Hagel, Alessandra Oliva, et al.
Infectious Diseases and Therapy (2025)
Open Access
Are cefiderocol or sulbactam/durlobactam better than alternative best available treatment for infection by carbapenem-resistant A. baumannii? A systematic literature review
Stamatis Karakonstantis, Πέτρος Ιωάννου, Diamantis P. Kofteridis
Infection (2025)
Open Access
From Clinical Trials to Real-World Experiences: Evidence About Cefiderocol Use and Potential Role in Empirical Therapy
Alessandro Russo, Francesca Serapide
Infectious Diseases and Therapy (2025)
Open Access
The Multifaceted Landscape of Healthcare-Associated Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
Alessandro Russo, Francesca Serapide
Microorganisms (2025) Vol. 13, Iss. 4, pp. 829-829
Open Access
Emerging Concepts for the Treatment of Biofilm-Associated Bone and Joint Infections with IV Fosfomycin: A Literature Review
Sara Tedeschi, Efthymia Giannitsioti, Christian Mayer
Microorganisms (2025) Vol. 13, Iss. 5, pp. 963-963
Open Access
Risk factors for the development of hospital-acquired pneumonia in patients with carbapenem-resistant Acinetobacter baumannii respiratory colonization and the role of multisite colonization: a multicenter retrospective study
Alessandro Russo, Francesca Serapide, Francesco Alessandri, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2025)
Open Access
Risk factors for infection after carbapenem-resistant Acinetobacter baumannii colonization
Maddalena Peghin, Filippo Givone, Maria De Martino, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2024)
Open Access | Times Cited: 3
Page 1

Scroll to top